What Businesses Should Know About Deconstruction Opportunities in the Coming Weeks St Louis, United States - February ...
Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase ...
A new publication DOI 10.29026/oes.2026.250031, discusses an integrated metasurface-freeform system enabled multi-focal ...
Greece has completed 53% of EU Recovery Fund milestones, securing €23.4B so far as the August 2026 deadline approaches.
Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track ...
Q4 2025 Earnings Call February 18, 2026 7:00 PM ESTCompany ParticipantsKevin Burke - President, CEO & ChairmanJeffrey ...
Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and ...
Upon exercise of the option and completion of the acquisition, AlphaTON would be entitled to an upfront cash payment at closing, equity consideration representing 10% of the fully diluted equity of ...
A high-dose rehabilitation therapy improves motor outcomes in infants with perinatal stroke, offering rare evidence to guide ...
CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.
Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.
3don MSN
Heads up, spring break travelers, airports are about to be packed — But here’s what you can do.
Cheaper flights are fueling a surge in travel demand, just as spring break season ramps up. Recent data from KAYAK shows that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results